Market News AIOpen the app

Helus Pharma Touts Positive Data for Depression Drug

TrialRead the original at Benzinga
Good for HELP

HLP003 cut symptoms more than placebo and raised the share of patients who improved or reached remission, supporting HELP's prospects. Most side effects were brief, but 3 serious events were tied to treatment and another Phase 3 study is underway.

HELP · Helus Pharma Inc.

AI read · Good for HELP

The AI's read

The size of the improvement and better patient response and remission rates point to a possible new option for people whose current medicines have not worked. Most side effects were short-lived. Investigators still recorded 3 serious events tied to treatment, and another Phase 3 study is underway.

Get alerts for HELP

Follow Helus Pharma Inc. (HELP) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for HELP
Free on the App Store and Google Play, or on the web.